Oncology: carg-2020
IL-12Amplify anti cancer immune response by inducing T cells
IL-17R antagonistExpand immune response by bocking tumor-promoting IL-17RA and its markers
shRNA-PD-L1Sustain anti-cancer immunity by blocking immune checkpoint pathway PD-L1 preventing T cell exhaustion

CARG-2020: Prevention of Tumor Recurrence; Potential Cure for Solid Tumors

CARG-2020 Efficacy and MoA Animation